NCT03184363

Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)

Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines: Multi-center, Single Arm, Open, Extension Study

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 102 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to explore the Efficacy and Safety of DWP450 for treating Crows Feet Lines(CFL) in combination with glabellar line(GL) as extension study of phase 3 study for CFL.

Conditions

• Crow's Feet Lines
• Glabellar Lines

Interventions

Type	Name	Description
DRUG	Clostridium Botulinum A Toxin	Clostridium Botulinum A Toxin

Timeline

• Start date: 2017-07-01
• Primary completion: 2017-10-01
• Completion: 2017-12-01
• First posted: 2017-06-12
• Last updated: 2017-06-12